* BioLife Solutions Inc BLFS.OQ reported quarterly breakeven
results per share for the quarter ended in September. The mean
expectation of nine analysts for the quarter was for a loss of 9
cents per share.
* Revenue rose 199.7% to $33.80 million from a year ago;
analysts expected $31.61 million.
* BioLife Solutions Inc's reported EPS for the quarter was
breakeven results.
* The mean earnings estimate of analysts had fallen by
about 97.8% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* BioLife Solutions Inc shares had risen by 17.2% this
quarter and gained 24.4% so far this year.
* The company reported quarterly net income of $79 thousand.
* Wall Street's median 12-month price target for BioLife
Solutions Inc is $61.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
This summary was machine generated November 11 at 10:49 p.m.
All figures in US dollars unless otherwise stated